Bill would ban COVID-19 vaccine mandates despite older adults remaining at highest risk for serious outcomes
By
Kimberly Bonvissuto
Nov 02, 2023
A study underscoring the need to continue to protect older adults from COVID-19 comes as one state appears close to banning COVID-19 vaccine mandates by private employers, including senior living communities.
SNF occupancy edges slightly up in October but is still down nearly 10 percent from last year: NIC
By
Amy Novotney
Jan 08, 2021
Occupancy rates at nursing homes across the country continued to be depressed in October, according to data from the latest Skilled Nursing Monthly Report, published by the National Investment Center for...
As HHS gives $4.9 billion to nursing homes, provider groups ‘disappointed’ that COVID-19 support...
By
Lois A. Bowers
Kimberly Bonvissuto
May 26, 2020
Nobody in long-term care is begrudging skilled nursing facilities for the $4.9 billion that began flowing to providers on Friday to fight effects of the COVID-19 pandemic, but associations are asking federal...
62 symptoms linked to SARS-CoV-2 infection after 12 weeks
Jul 28, 2022
The highest adjusted hazard ratios were seen for anosmia, hair loss, sneezing, ejaculation difficulty and reduced libido.
SARS-CoV-2 infection cuts risk for reinfection for up to 10 months
Jun 15, 2021
The risk for PCR-positive infection higher for residents and staff members of long-term care facilities who were antibody-negative at baseline.
Signs/symptoms may ID COVID-19 even with negative RT-PCR
Feb 24, 2022
Patients who repeatedly tested negative but had signs/symptoms of COVID-19 had similar seroprevalence as RT-PCR-confirmed cases.
Two doses of mRNA-1273 effective against SARS-CoV-2 variants
Dec 15, 2021
Vaccine effectiveness against infection with delta variant declines with increasing time since vaccination.
Odds of SARS-CoV-2 infection down after third BNT162b2 dose
Dec 03, 2021
The estimated odds ratio of 0.14 at 28 to 65 days after receipt of the Pfizer-BioNTech booster was compared with those who received two doses.
Third BNT162b2 vaccine dose may cut severe COVID-19 outcomes
Nov 05, 2021
Fewer hospital admissions, cases of severe disease and COVID-19-related deaths were seen with the third dose of the Pfizer-BioNTech vaccine versus two doses received five months ago.
Allergy history may up risk for reactions to mRNA COVID-19 vaccine
Nov 04, 2021
The risk for allergic reactions within three days of vaccination is higher for those with history of high-risk allergy, but most completed the two-dose regimen. The mRNA vaccines approved for use against...